SCHEMBL24372502

SCHEMBL24372502

c1ccc(-c2nc(-c3ccc(-c4ccc(-c5ccc6ccccc6c5)cc4)cc3)nc(-c3cccc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
HSD17B10 Q99714 3/20 0.43
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 3/20 0.39
HPGD P15428 2/20 0.39
TSHR P16473 2/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
ATM Q13315 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21108852 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL22483253 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL26231353 0.99 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL24372504 0.99 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL24655167 0.99 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL23821102 0.99 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL21149113 0.99 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL23821071 0.99 ALDH1A1 (0.40) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL24372646 0.99 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2
SCHEMBL23821072 0.97 ALDH1A1 (0.40) ALDH1A1KDM4EHSD17B10TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131083-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131083-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME TELO2, TERT, LIMS1 ALDH1A1 275/4885KDM4E 3373/4885HSD17B10 4286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.